14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Jun 01, 2026
MCSE vs ABVE: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Jun 01, 2026, Above Food Ingredients Inc. (ABVE) is the stronger overall head-to-head candidate over Franklin Templeton ETF Trust Franklin Sustainable International Equity ETF (MCSE) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MCSE carries a Unified Composite Score of 53.9/100 (HOLD) at $13.82 (N/M Forward P/E, N/A operating margin), whereas ABVE carries 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin).
Composite vs. Pillar Nuance: While MCSE currently prints a higher short-term Unified Composite Score (53.9/100 HOLD vs. ABVE 39.8/100 SELL), ABVE captures the overall institutional head-to-head verdict (5–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (-23.2% vs. N/A operating margin) and revenue trajectory (-45.0% vs. N/A YoY).
Technical & Structure Timing Caution: MCSE is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.4); meanwhile ABVE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MCSE vs ABVE. Trailing 12-month operating profitability (MCSE N/A vs ABVE -23.2%) and valuation multiples (MCSE N/M vs ABVE N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Packaged Foods value chain with $30.0M market capitalization and -23.2% operating margin.
OpEx & R&D Reinvestment20.4% of Rev ($60M)
90D Engineering Disclosures0 Published
Investor FAQ MCSE vs ABVE Key Questions & Quantitative Answers
As of Jun 01, 2026, Above Food Ingredients Inc. (ABVE) is the stronger overall head-to-head candidate over Franklin Templeton ETF Trust Franklin Sustainable International Equity ETF (MCSE) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MCSE carries a Unified Composite Score of 53.9/100 (HOLD) at $13.82 (N/M Forward P/E, N/A operating margin), whereas ABVE carries 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin). Composite vs. Pillar Nuance: While MCSE currently prints a higher short-term Unified Composite Score (53.9/100 HOLD vs. ABVE 39.8/100 SELL), ABVE captures the overall institutional head-to-head verdict (5–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (-23.2% vs. N/A operating margin) and revenue trajectory (-45.0% vs. N/A YoY). Technical & Structure Timing Caution: MCSE is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.4); meanwhile ABVE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ABVE leads the Growth & Scale pillar: MCSE posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with ABVE at -45.0% YoY revenue growth and +0.0% YoY earnings growth on $295M TTM revenue (-2.8% gross margin, -23.2% operating margin). On trailing 12-month operating scale, MCSE generates N/A in USD-normalized revenue versus $295M for ABVE. In operating R&D and SG&A reinvestment, MCSE deploys N/A (0 90-day corporate R&D disclosures) versus 20.4% of Rev ($60M) (0 disclosures) for ABVE.
ABVE screens cheaper on headline valuation multiples. MCSE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ABVE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MCSE (N/A ROE) versus ABVE (0.0% ROE) capital efficiency.
In options market volatility and institutional positioning, MCSE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.87β · 18% Vol realized risk). By comparison, ABVE carries 148.3% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.10β · 310% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Jun 01, 2026. For educational research only; not investment advice.